Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?

Mohamed, Mahmoud M A; El-Shimy, Ismail Amr; Hadi, Muhammad Abdul

Mohamed, Mahmoud M A; El-Shimy, Ismail Amr; Hadi, Muhammad Abdul.

Mohamed MMA; Department of Radiology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
El-Shimy IA; Integrative Research Institute (IRI) for Life Sciences, Humboldt University Berlin, Philippstrasse 13, 10115, Berlin, Germany.
Hadi MA; Institute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Crit Care ; 24(1): 311, 2020 06 08.

Article in English | MEDLINE | ID: covidwho-574525

Subject(s)

Coronavirus Infections/complications; Coronavirus Infections/drug therapy; Pneumonia, Viral/complications; Pneumonia, Viral/drug therapy; Proteinase Inhibitory Proteins, Secretory/therapeutic use; Respiratory Distress Syndrome/drug therapy; Respiratory Distress Syndrome/virology; COVID-19; Clinical Trials as Topic; Coronavirus Infections/epidemiology; Hospitalization; Humans; Pandemics; Pneumonia, Viral/epidemiology; Severity of Illness Index; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Coronavirus Infections / Proteinase Inhibitory Proteins, Secretory Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Crit Care Year: 2020 Document Type: Article Affiliation country: S13054-020-03023-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google